Company Filing History:
Years Active: 2002
Title: Beatrice Ann Dalton – Innovator in Corneal Implant Technology
Introduction
Beatrice Ann Dalton, an influential inventor based in Narrabeen, Australia, has made significant contributions to the field of ocular health. With her expertise and dedication, she has developed innovative solutions to enhance vision through her patented invention.
Latest Patents
Beatrice holds one patent for her groundbreaking work on corneal onlays. This invention involves a corneal implant made from a biocompatible, optically transparent, synthetic, and biostable polymeric material. The corneal onlay is designed to be placed within or onto the surface of the cornea, promoting the attachment and growth of tissue cells. The topography of the implant features a plurality of surface indentations, which facilitates the attraction and attachment of epithelial tissue, ultimately enhancing the healing process and vision quality for patients.
Career Highlights
Currently, Beatrice Ann Dalton is employed with Novartis AG, a leading global healthcare company. Her work at Novartis highlights her commitment to advancing medical technologies and improving patient outcomes in ophthalmology.
Collaborations
Throughout her career, Beatrice has collaborated with notable professionals, including John Gerard Steele and Margaret Diana Macrea Evans. These collaborations have allowed her to combine expertise and foster innovation, contributing to the success of her projects and advancements in the medical field.
Conclusion
Beatrice Ann Dalton's contributions to corneal implant technology exemplify the importance of innovation in medicine. Her patent on the corneal onlay not only represents a significant achievement in ocular health but also demonstrates her commitment to improving the quality of life for individuals with vision impairments. As she continues her work at Novartis AG, there is no doubt that Beatrice will keep pushing the boundaries of medical innovation.